Literature DB >> 34529960

Ebola vaccines for mass immunisation in affected regions.

Selidji Todagbe Agnandji1, Marguerite Massinga Loembe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34529960     DOI： 10.1016/S1473-3099(21)00226-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  1 in total

1.  Protein Folding Interdiction Strategy for Therapeutic Drug Development in Viral Diseases: Ebola VP40 and Influenza A M1.

Authors:  Fernando Bergasa-Caceres; Herschel A Rabitz
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.